Determination of MICs of levofloxacin for <I>Mycobacterium tuberculosis</I> with <I>gyr</I>A mutations

Abstract

Patients reported negative experiences with previous HIV and anti-tuberculosis treatment. Access to early diagnosis and rapid initiation of integrated care for HIV-MDR-TB co-infected patients, with a strong, patient-centered support system, could help to combat the low morale and lack of faith in treatment described in this group of patients.